Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Maintaining a healthy weight can feel like a daunting task in today's fast-paced world. With the myriad of diet plans, exercise regimens, and weight loss pills on the market, finding a solution that ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

Leaders of the Common Sense Oncology initiative, launched 1.5 years ago as “a new patient-centered movement in cancer care,” outline principles for trial design, analysis, and reporting.

A spokesperson for the Cholangiocarcinoma Foundation writes that experimental cancer trials saved her life and could save the ...

The Lupus Therapeutics (LT) PALS Program: Empowering Lupus Patients Through Peer Advocacy and Clinical Trial Inclusion Lupus is a chronic autoimmune disease that disproportionately affects racial and ...

A growing number of U.S veterans, desperate to treat PTSD, are turning to psychedelics. They're headed to other countries, ...

Minutes joined U.S. veterans with PTSD as they attend a week-long psychedelic retreat in Mexico. Nearly a year later, most of ...

Dr. Blackman co-founded Day One Biopharmaceuticals in 2018 with a vision to identify, acquire, and develop promising new treatments to address childhood cancers. Under Dr. Blackman’s leadership, Day ...